XIth Eurasian Hematology-Oncology Congress - EHOC 2020
How I Manage CML at MD Anderson in 2020: Are 1L Therapies Getting Better, Safer & Cheaper? Is There a Difference Between 2L Options? Is 3L Ponatinib Effective? Are Dose Reductions Effective and Safe? Is TFR Feasible?
Comments 0
Login to view comments.
Click here to Login
